{
  "meta": {
    "title": "Autonomic nervous system",
    "url": "https://brainandscalpel.vercel.app/autonomic-nervous-system-4ae7bfa1-508e31.html",
    "scrapedAt": "2025-12-01T05:08:34.371Z",
    "type": "article"
  },
  "content": "\n                <div><h1>Introduction</h1>\n<p>The autonomic nervous system controls most of the visceral functions of the body, including regulation of circulation, digestion, and urination.&nbsp; It has 2 complementary components with opposite effects:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>The sympathetic nervous system (fight or flight response).</li>\n\t<li>The parasympathetic nervous system (rest and digest response).</li>\n</ul><br><br><p>Specialized portions of the CNS react to inputs from peripheral receptors (eg, baroreceptors, chemoreceptors) and transmit outputs that respond to changes in the environment and help maintain physiologic stability.</p>\n<h1>Overview</h1><br><br><p>The output from the sympathetic and parasympathetic nervous systems travels from the CNS along a preganglionic neuron and is transmitted to a postganglionic neuron (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L74296.jpg\" alt=\"figure 1\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 1</div>\n                                </div>\n                                ).&nbsp; The features of each system are as follows:<p></p>\n<h2>Sympathetic nervous system&nbsp;</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>The preganglionic neuron travels from the spinal cord to the <strong>nearby sympathetic chain</strong> in the peripheral nervous system.</li>\n\t<li>The <strong>preganglionic</strong> neuron transmits a signal using <strong>acetylcholine</strong>, which is received by <strong>nicotinic receptors</strong> on the postganglionic neuron.</li>\n\t<li>The <strong>postganglionic</strong> neuron connects to the effector organ and transmits a signal using <strong>norepinephrine</strong>, which is received by <strong>adrenergic receptors</strong> on the effector organ.\n\t<ul class=\"article-body-unordered-list\">\n\t\t<li>End-organ adrenergic receptors have several subtypes, including alpha 1, alpha 2, beta 1, and beta 2.</li>\n\t</ul>\n\t</li>\n\t<li>Two <strong>exceptions</strong> to the standard sympathetic nervous system architecture include:\n\t<ul class=\"article-body-unordered-list\">\n\t\t<li>The adrenal glands, which are innervated by a single neuron coming directly from the CNS and release epinephrine directly into the bloodstream.</li>\n\t\t<li>The sweat glands, which are innervated by postganglionic neurons that use acetylcholine (and stimulate muscarinic receptors) rather than norepinephrine.</li>\n\t</ul>\n\t</li>\n</ul>\n<h2>Parasympathetic nervous system&nbsp;</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>The preganglionic neuron travels from the brain or sacral spinal cord to a <strong>distant ganglion</strong> in the peripheral nervous system.</li>\n\t<li>As in the sympathetic nervous system, the <strong>preganglionic neuron</strong> transmits a signal using <strong>acetylcholine</strong>, which is received by <strong>nicotinic receptors</strong> on the postganglionic neuron.</li>\n\t<li>The <strong>postganglionic neuron</strong> connects to the effector organ and transmits a signal using <strong>acetylcholine</strong>, which is received by <strong>muscarinic receptors</strong> on the effector organ.\n\t<ul class=\"article-body-unordered-list\">\n\t\t<li>End-organ muscarinic receptors have several subtypes, including muscarinic receptor subtype 1 (M1), muscarinic receptor subtype 2 (M2), and muscarinic receptor subtype 3 (M3).</li>\n\t</ul>\n\t</li>\n</ul><br><br><p>Once the autonomic receptors of an effector organ receive an autonomic signal, a <strong>protein-coupled</strong> mechanism (often a G protein (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L26299.jpg\" alt=\"figure 2\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 2</div>\n                                </div>\n                                )) is triggered, and a cascade involving a second messenger system ensues to create a specific <strong>cellular response</strong> (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/108754.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 1\n                                    </a>\n                                </div>\n                                ).&nbsp; Most end-organ autonomic receptors use the cyclic adenosine monophosphate (cAMP) second messenger system, whereas some receptors use the inositol triphosphate/diacylglycerol (IP<font size=\"2\"><sub>3</sub></font>/DAG) system.&nbsp; The cyclic guanosine monophosphate (cGMP) system responds to nitric oxide and plays a subsidiary role during beta 2 receptor and M3 receptor stimulation.<p></p>\n<h1>Autonomic receptor distribution and function</h1><br><br><p>The types of receptors in the autonomic nervous system are summarized in this table (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125879.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 2\n                                    </a>\n                                </div>\n                                ).&nbsp; They consist of nicotinic, adrenergic, and muscarinic receptors.<p></p>\n<h2>Nicotinic receptors&nbsp;</h2><br><br><p>Nicotinic-1 receptors are located in autonomic ganglia at the dendritic (receiving) end of <strong>postganglionic</strong> neurons (in <strong>both</strong> the sympathetic and parasympathetic nervous systems) and are stimulated by <strong>acetylcholine</strong>.&nbsp; Nicotinic-1 receptors differ from nicotinic-2 receptors located on skeletal muscle in the somatic nervous system (motor neurons), which are also stimulated by acetylcholine.</p>\n<h2>Adrenergic receptors&nbsp;</h2><br><br><p>Postganglionic sympathetic neurons typically transmit signals to their effector organs using norepinephrine, which is received by adrenergic receptors.</p>\n<h2>Alpha-1 adrenergic receptors&nbsp;</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Location:&nbsp; <strong>Vascular smooth muscle</strong>, iris of the eye, bladder neck, urethral epithelium.</li>\n\t<li>Signaling pathway:&nbsp; <strong>G<font size=\"2\"><sub>q</sub></font> protein</strong> â†’ phospholipase C â†’ <strong>IP<font size=\"2\"><sub>3</sub></font>/DAG</strong> â†’ â†‘ Ca<font size=\"2\"><sup>2+</sup></font> and protein kinase C.</li>\n\t<li>Cellular effect is <strong>stimulatory</strong>:&nbsp; â†‘ Ca<font size=\"2\"><sup>2+</sup></font> activates myosin light-chain kinase and triggers smooth muscle contraction.&nbsp; Protein kinase C also contributes to smooth muscle contraction.</li>\n\t<li>Clinical effects:&nbsp; â†‘ Systemic vascular resistance, pupillary dilation, urinary retention.</li>\n</ul>\n<h2>Alpha-2 adrenergic receptors&nbsp;</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Location:&nbsp; Primarily within the <strong>CNS</strong>.&nbsp; Some receptors in the gastrointestinal and genitourinary tracts.</li>\n\t<li>Signaling pathway:&nbsp; <strong>G<font size=\"2\"><sub>i</sub></font> protein</strong> â†’ inhibition of adenylyl cyclase â†’ <strong>â†“ cAMP</strong> â†’ â†“ protein kinase A.</li>\n\t<li>Cellular effect is <strong>inhibitory</strong>:&nbsp; â†“ Norepinephrine release and neuronal hyperpolarization create an inhibitory effect on sympathetic output.</li>\n\t<li>Clinical effects:&nbsp; â†“ Blood pressure and heart rate, â†‘ digestive enzyme secretion.</li>\n</ul>\n<h2>Beta-1 adrenergic receptors&nbsp;</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Location:&nbsp; <strong>Myocardial contractile and conductive tissue</strong>, juxtaglomerular apparatus of the kidneys.</li>\n\t<li>Signaling pathway:&nbsp; <strong>G<font size=\"2\"><sub>s</sub></font> protein</strong> â†’ stimulation of adenylyl cyclase â†’ <strong>â†‘ cAMP</strong> â†’ â†‘ protein kinase A.</li>\n\t<li>Cellular effect is <strong>stimulatory</strong>:&nbsp; â†‘ intracellular Ca<font size=\"2\"><sup>2+</sup></font> activates myosin light-chain kinase in cardiac muscle, â†‘ cAMP stimulates ion channel activity.</li>\n\t<li>Clinical effect:&nbsp; â†‘ Contractility and heart rate, â†‘ renin release.</li>\n</ul>\n<h2>Beta-2 adrenergic receptors&nbsp;</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Location:&nbsp; <strong>Lung bronchiolar</strong> smooth muscle, vascular smooth muscle and vascular endothelium.</li>\n\t<li>Signaling pathway:&nbsp; <strong>G<font size=\"2\"><sub>s</sub></font> protein</strong> â†’ stimulation of adenylyl cyclase â†’ <strong>â†‘ cAMP</strong> â†’ â†‘ protein kinase A.</li>\n\t<li>Cellular effect is <strong>stimulatory</strong>:&nbsp; â†‘ cAMP in smooth muscle â†’ inhibition of myosin light-chain kinase (Ca<font size=\"2\"><sup>2+</sup></font> independent), â†‘ intracellular Ca<font size=\"2\"><sup>2+</sup></font> in endothelium â†’ â†‘ nitric oxide.</li>\n\t<li>Clinical effect:&nbsp; Smooth muscle relaxation (bronchodilation, vasodilation).</li>\n</ul>\n<h2>Muscarinic receptors&nbsp;</h2><br><br><p>Postganglionic parasympathetic neurons typically transmit signals to their effector organs using acetylcholine, which is received by muscarinic receptors.</p>\n<h2>Muscarinic receptor subtype 1&nbsp;</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Location:&nbsp; Most M1 receptors are in the <strong>cerebral cortex</strong> and are not part of the autonomic nervous system.&nbsp; Those that are part of the autonomic nervous system are primarily within the <strong>digestive system</strong>.</li>\n\t<li>Signaling pathway:&nbsp; <strong>G<font size=\"2\"><sub>q</sub></font> protein</strong> â†’ phospholipase C â†’ <strong>IP<font size=\"2\"><sub>3</sub></font>/DAG</strong> â†’ â†‘ Ca<font size=\"2\"><sup>2+</sup></font> and protein kinase C.</li>\n\t<li>Cellular effect is <strong>stimulatory</strong>:&nbsp; â†‘ Ca<font size=\"2\"><sup>2+</sup></font> activates myosin light-chain kinase and triggers smooth muscle contraction.</li>\n\t<li>Clinical effect:&nbsp; Digestive smooth muscle contraction (peristalsis).</li>\n</ul>\n<h2>Muscarinic receptor subtype 2&nbsp;</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Location:&nbsp; <strong>Myocardial</strong> conduction and contractile tissue.</li>\n\t<li>Signaling pathway:&nbsp; <strong>G<font size=\"2\"><sub>i</sub></font> protein</strong> â†’ inhibition of adenylyl cyclase â†’ â†“ <strong>cAMP</strong> â†’ â†“ protein kinase A.</li>\n\t<li>Cellular effect is <strong>inhibitory</strong>:&nbsp; â†“ Norepinephrine release and neuronal hyperpolarization create an inhibitory effect on sympathetic output.</li>\n\t<li>Clinical effect:&nbsp; â†“ Automaticity and conduction rate, â†“ contractility (slight effect).</li>\n</ul>\n<h2>Muscarinic receptor subtype 3&nbsp;</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Location:&nbsp; Lung bronchioles, iris of the eye, urinary bladder, gastrointestinal tract, vascular endothelium.</li>\n\t<li>Signaling pathway:&nbsp; <strong>G<font size=\"2\"><sub>q</sub></font> protein</strong> â†’ phospholipase C â†’ <strong>IP<font size=\"2\"><sub>3</sub></font>/DAG</strong> â†’ â†‘ Ca<font size=\"2\"><sup>2+</sup></font> and protein kinase C.</li>\n\t<li>Cellular effect is <strong>stimulatory</strong>:&nbsp; â†‘ Ca<font size=\"2\"><sup>2+</sup></font> activates myosin light-chain kinase and triggers smooth muscle contraction and other effects.</li>\n\t<li>Clinical effect:&nbsp; Smooth muscle contraction (bronchoconstriction, pupillary constriction, bladder contraction), enzyme excretion, â†‘ intestinal motility, and vasodilation via nitric oxide.</li>\n</ul><br><br><p>The autonomic receptor characteristics and major clinical effects of receptor stimulation are summarized here (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/38888.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 3\n                                    </a>\n                                </div>\n                                , \n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125880.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 4\n                                    </a>\n                                </div>\n                                , \n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125918.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 5\n                                    </a>\n                                </div>\n                                ).<p></p>\n<h1>Pharmacology of the autonomic nervous system</h1><br><br><p>Many important pharmacologic agents act by binding to autonomic receptors on effector organs (or occasionally within the CNS or peripheral autonomic ganglia) to modulate the effects of the autonomic nervous system.&nbsp; These drugs fall into 2 main categories:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Agonists</strong>:&nbsp; Bind to autonomic receptors to produce the same cellular effect as an endogenous neurotransmitter (ie, an agonist mimics the endogenous neurotransmitter).&nbsp; When an agonist is administered, the cellular response is amplified.</li>\n\t<li><strong>Antagonists</strong> (also called blockers or inhibitors):&nbsp; Bind to autonomic receptors to prevent endogenous neurotransmitters from binding to those receptors, effectively blocking the downstream cellular response.&nbsp; When an antagonist is administered, the cellular response is reduced.</li>\n</ul><br><br><p>The typical end-organ neurotransmitter for the sympathetic nervous system is norepinephrine (or less commonly epinephrine or dopamine) and for the parasympathetic nervous system is acetylcholine.</p><br><br><p>Pharmacologic agents that affect the autonomic nervous system have varying affinities for different adrenergic and muscarinic receptor subtypes; therefore, knowledge of the subtypes and their locations within the body is needed to understand the effects of particular pharmacologic agents.</p>\n<h2>Alpha-1 adrenergic receptor agonists&nbsp;</h2><br><br><p>Alpha-1 receptor agonists induce <strong>smooth muscle contraction</strong> in the specific organs and tissues where these receptors are located, including vascular smooth muscle, the iris of the eye, and the bladder neck/urethra.&nbsp; Examples of alpha-1 receptor agonists include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Phenylephrine.</li>\n\t<li>Midodrine.</li>\n\t<li>Naphazoline, oxymetazoline.</li>\n</ul><br><br><p>The pharmacologic effects, therapeutic uses, and adverse effects of these alpha-1 receptor agonists are summarized here (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125919.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 6\n                                    </a>\n                                </div>\n                                ).<p></p>\n<h2>Alpha-2 receptor agonists&nbsp;</h2><br><br><p>Alpha-2 receptor agonists primarily reduce <strong>sympathetic outflow</strong> from the <strong>CNS</strong>.&nbsp; Examples of alpha-2 receptor agonists include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Clonidine.</li>\n\t<li>Methyldopa.</li>\n\t<li>Guanfacine.</li>\n\t<li>Dexmedetomidine.</li>\n\t<li>Tizanidine.</li>\n\t<li>Brimonidine, apraclonidine.</li>\n</ul><br><br><p>The pharmacologic effects, therapeutic uses, and adverse effects of these alpha-2 receptor agonists are summarized here (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125920.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 7\n                                    </a>\n                                </div>\n                                ).<p></p>\n<h2>Beta receptor agonists&nbsp;</h2><br><br><p>Beta receptor agonists generally stimulate beta 1 (eg, <strong>heart</strong>) and beta 2 (eg, <strong>lung</strong>) receptors with varying relative strength.&nbsp; Beta receptor agonists include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Dobutamine (beta 1 &gt; beta 2).</li>\n\t<li>Isoproterenol (beta 1 = beta 2).</li>\n\t<li>Albuterol (beta 2 &gt; beta 1).</li>\n</ul>\n<h2>Mixed alpha and beta receptor agonists&nbsp;</h2><br><br><p>Similarly, mixed alpha and beta agonists generally stimulate alpha and beta receptors with varying strength.&nbsp; Mixed alpha and beta agonists include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Dopamine (relative stimulation is dose dependent):\n\t<ul class=\"article-body-unordered-list\">\n\t\t<li>Low dose:&nbsp; Dopamine 1 &gt; beta 1 &gt; alpha 1.</li>\n\t\t<li>High dose:&nbsp; Alpha 1 &gt; beta 1 &gt; dopamine 1.</li>\n\t</ul>\n\t</li>\n\t<li>Epinephrine (relative stimulation is dose dependent):\n\t<ul class=\"article-body-unordered-list\">\n\t\t<li>Low dose:&nbsp; Beta 1 &gt; beta 2 &gt; alpha 1.</li>\n\t\t<li>High dose:&nbsp; Alpha 1 &gt; beta 1 &gt; beta 2.</li>\n\t</ul>\n\t</li>\n\t<li>Norepinephrine (alpha 1 &gt; beta 1 &gt; beta 2).</li>\n</ul><br><br><p>The pharmacologic effects of adrenergic agonists are primarily cardiovascular and are summarized here (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125987.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 8\n                                    </a>\n                                </div>\n                                ).&nbsp; Albuterol is not included in the table because it is used primarily in an inhaled form to induce bronchodilation.<p></p>\n<h2>Muscarinic receptor agonists&nbsp;</h2><br><br><p>Muscarinic agonists mimic the action of <strong>acetylcholine</strong> and include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Bethanechol.</li>\n\t<li>Methacholine.</li>\n\t<li>Pilocarpine.</li>\n</ul><br><br><p><strong>Acetylcholinesterase inhibitors</strong> produce a muscarinic agonist effect by inhibiting the degradation of acetylcholine and include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Donepezil.</li>\n\t<li>Neostigmine.</li>\n\t<li>Physostigmine.</li>\n\t<li>Rivastigmine.</li>\n</ul><br><br><p>The pharmacologic effects, therapeutic uses, and adverse effects of these muscarinic agonists are summarized here (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125921.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 9\n                                    </a>\n                                </div>\n                                ).<p></p>\n<h2>Alpha receptor antagonists (blockers)&nbsp;</h2><br><br><p>Alpha-1 receptor antagonists <strong>prevent smooth muscle contraction</strong>.&nbsp; These drugs end in the suffix \"-osin,\" and examples include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Doxazosin, prazosin, terazosin.</li>\n\t<li>Tamsulosin, alfuzosin.</li>\n</ul><br><br><p>Alpha-2 receptor antagonists <strong>increase central sympathetic outflow</strong>.&nbsp; These drugs include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Yohimbine.</li>\n\t<li>Idazoxan.</li>\n</ul><br><br><p>Nonselective alpha antagonists block both alpha 1 and alpha 2 receptors and include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Phenoxybenzamine (irreversible alpha blockade).</li>\n\t<li>Phentolamine.</li>\n</ul><br><br><p>The pharmacologic effects, therapeutic uses, and adverse effects of these alpha receptor antagonists are summarized here (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125984.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 10\n                                    </a>\n                                </div>\n                                ).<p></p>\n<h2>Beta receptor antagonists (blockers)</h2><br><br><p><strong>Selective beta-1</strong> receptor antagonists primarily <strong>block sympathetic input to the heart</strong> and include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Bisoprolol.</li>\n\t<li>Atenolol.</li>\n\t<li>Metoprolol.</li>\n\t<li>Esmolol.</li>\n</ul><br><br><p>There are no selective beta-2 receptor antagonists, but <strong>nonselective beta antagonists</strong> block both beta 1 and beta 2 receptors and include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Propranolol.</li>\n\t<li>Nadolol.</li>\n\t<li>Timolol.</li>\n\t<li>Sotalol.</li>\n</ul><br><br><p>Mixed alpha 1 and nonselective beta antagonists include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Carvedilol.</li>\n\t<li>Labetalol.</li>\n</ul><br><br><p>The pharmacologic effects, therapeutic uses, and adverse effects of these beta receptor antagonists are summarized here (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125985.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 11\n                                    </a>\n                                </div>\n                                ).<p></p><br><br><p><strong>Muscarinic receptor antagonists (blockers)</strong></p><br><br><p>Muscarinic receptor antagonists reduce cholinergic activity and include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Atropine.</li>\n\t<li>Glycopyrrolate.</li>\n\t<li>Scopolamine.</li>\n\t<li>Ipratropium, tiotropium, aclidinium.</li>\n\t<li>Oxybutynin.</li>\n\t<li>Dicyclomine.</li>\n</ul><br><br><p>The pharmacologic effects, therapeutic uses, and adverse effects of these muscarinic receptor antagonists are summarized here (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125986.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 12\n                                    </a>\n                                </div>\n                                ).<p></p><br><br><p>The cardiovascular effects of autonomic receptor antagonists are summarized here (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/125988.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 13\n                                    </a>\n                                </div>\n                                ).<p></p>\n<h1>Summary</h1><br><br><p>The autonomic nervous system has 2 complementary components with opposite effects: the sympathetic nervous system (fight or flight response) and the parasympathetic nervous system (rest and digest response).&nbsp; These systems contain preganglionic neurons that initiate in the CNS and synapse at an autonomic ganglion in the peripheral nervous system.&nbsp; In the autonomic ganglion, acetylcholine transmits a signal to nicotinic receptors on the postganglionic neuron that then synapses on an effector organ.&nbsp; The end-organ effects of the sympathetic nervous system are mediated by adrenergic receptors in response to norepinephrine, and those of the parasympathetic nervous system are mediated by muscarinic receptors in response to acetylcholine.&nbsp; Many pharmacologic agents function via stimulation (agonist effect) or blockade (antagonist effect) of these adrenergic or muscarinic receptors.</p>\n</div>\n\n            "
}